216 related articles for article (PubMed ID: 26134018)
21. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
[TBL] [Abstract][Full Text] [Related]
22. Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis.
Song Y; Wang J; Wang Y; Wu L; Wang Z
Cancer Biol Ther; 2021 Dec; 22(10-12):598-606. PubMed ID: 34724875
[TBL] [Abstract][Full Text] [Related]
23. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
[TBL] [Abstract][Full Text] [Related]
24. [Comparative Analysis of Primary and Reactivated EB Virus Infection Associated Hemophagocytic Lymphohistiocytosis].
Liu JH; Liu W; Li YG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):575-580. PubMed ID: 37096536
[TBL] [Abstract][Full Text] [Related]
25. Treatment outcomes and prognostic factors for non- malignancy associated secondary hemophagocytic lymphohistiocytosis in children.
Pan H; Wang G; Guan E; Song L; Song A; Liu X; Yi Z; Sun LR
BMC Pediatr; 2020 Jun; 20(1):288. PubMed ID: 32517812
[TBL] [Abstract][Full Text] [Related]
26. Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol.
Yanagaisawa R; Matsuda K; Ohga S; Kanegane H; Morimoto A; Okamoto Y; Ohara A; Fukushima K; Sotomatsu M; Nomura K; Saito AM; Horibe K; Ishii E; Nakazawa Y
Int J Hematol; 2019 May; 109(5):612-617. PubMed ID: 30788725
[TBL] [Abstract][Full Text] [Related]
27. Disparity Analysis of Clinical Features and Prognostic Evaluation of Hemophagocytic Lymphohistiocytosis in Pediatric and Adult Patients: A Retrospective Multicenter Study of 525 Cases in HHLWG.
Wang X; Zhou Y; Sun Q; Zhou H; Zhang Q; Shen Z; Huang J; Xue Y; Yan D; Fang Y; Sang W
Acta Haematol; 2023; 146(3):185-195. PubMed ID: 36623498
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol.
Lee JS; Kang JH; Lee GK; Park HJ
J Korean Med Sci; 2005 Apr; 20(2):209-14. PubMed ID: 15831988
[TBL] [Abstract][Full Text] [Related]
29. [Characteristic and prognosis of patients with non-EBV infection-associated hemophagocytic lymphohistiocytosis].
You YH; Wang JS; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2022 Feb; 43(2):128-133. PubMed ID: 35381673
[No Abstract] [Full Text] [Related]
30. Clinical features and outcomes of patients with hemophagocytic lymphohistiocytosis at onset of systemic autoinflammatory disorder and compare with Epstein-Barr virus (EBV)-related hemophagocytic lymphohistiocytosis.
Zhao Y; Li Z; Zhang L; Lian H; Ma H; Wang D; Zhao X; Zhang Q; Wang T; Zhang R
Medicine (Baltimore); 2020 Jan; 99(1):e18503. PubMed ID: 31895784
[TBL] [Abstract][Full Text] [Related]
31. Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection.
Li Y; Li S; Lu N; Wang W; Wang D
Ann Hematol; 2024 May; 103(5):1541-1547. PubMed ID: 38467825
[TBL] [Abstract][Full Text] [Related]
32. Nivolumab treatment of relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults.
Liu P; Pan X; Chen C; Niu T; Shuai X; Wang J; Chen X; Liu J; Guo Y; Xie L; Wu Y; Liu Y; Liu T
Blood; 2020 Mar; 135(11):826-833. PubMed ID: 31914172
[TBL] [Abstract][Full Text] [Related]
33. Lymphoma-based therapy for refractory or relapsed Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in children.
Cheng CN; Chu WY; Chang KC; Chen JS
J Formos Med Assoc; 2022 Nov; 121(11):2351-2355. PubMed ID: 35123848
[TBL] [Abstract][Full Text] [Related]
34. [Expression Profile and Clinical Significance of Cytokines and Chemokines in Patients with Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis].
Gao Y; Zheng Y; Zhang WH; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):268-273. PubMed ID: 36765510
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous Recovery of Hemophagocytic Lymphohistiocytosis Due to Primary Epstein-Barr Virus Infection in an Adult Patient.
Matsuo Y; Iwanami K; Hiraoka E; Oda R
Am J Case Rep; 2021 Oct; 22():e933272. PubMed ID: 34657119
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients.
Zhao A; Yang J; Li M; Li L; Gan X; Wang J; Li H; Shen K; Yang Y; Niu T
Front Immunol; 2022; 13():882589. PubMed ID: 35479073
[TBL] [Abstract][Full Text] [Related]
37. Assessment of immunochemotherapy and stem cell transplantation on EBV-associated hemophagocytic lymphohistiocytosis in children: a systematic review and meta analysis.
Qin Q; Xie Z; Shen Y; Yang S; Liu C; Huang Z; Xu J; Al J; Shen K
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):672-8. PubMed ID: 22774410
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report.
Chen RY; Li XZ; Lin Q; Zhu Y; Shen YY; Xu QY; Zhu XM; Bai ZJ; Li Y
BMC Pediatr; 2020 Oct; 20(1):456. PubMed ID: 33008347
[TBL] [Abstract][Full Text] [Related]
39. Prognostic scoring system for pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis based on baseline characteristics: A multicenter retrospective study.
Kong Q; Li M; Wang J; Wu L; Zhou D; Yang M; Xu X; Tan Z; Wu X; Wang Z
Pediatr Blood Cancer; 2024 Feb; 71(2):e30772. PubMed ID: 37974392
[TBL] [Abstract][Full Text] [Related]
40. [Ruxolitinib combined with liposomal doxorubicin, etoposide, methylprednisolone+/-PEG-asparaginase in treatment of relapsed/refractory pediatric hemophagocytic lymphohistiocytosis].
Wei A; Ma HH; Zhang LP; Lian HY; Du JY; Wang D; Cui L; Ou WX; Zhao YZ; Zhao XX; Zhang L; Li ZG; Wang TY; Zhang R
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2167-2172. PubMed ID: 35872580
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]